Literature DB >> 8464350

Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

R Korth1, J Bidault, R Palmantier, J Benveniste, E Ninio.   

Abstract

Intact washed human platelets aggregated in response to paf-acether (paf) and did not metabolize [3H]paf at concentrations up to 10 nM. However, when platelets were lysed by exposure to pH 9.5, resulting in 37.5 +/- 2.5% (mean +/- SD, n = 3) lactic dehydrogenase (LDH) release, 20.5 +/- 5.7% of the radioactivity was detected as labeled lyso paf and 5.7 +/- 3.1% as labeled alkylacylglycerophosphocholine. When platelets were aggregated with 0.5 IU/mL thrombin or high concentrations of paf (100 nM), they released a part of their acetylhydrolase without releasing LDH. In supernatants obtained from aggregated platelets, 21 +/- 2% or 10 +/- 2% (n = 3), respectively, of the total platelet acetylhydrolase activity was detected vs. none in supernatants of resting cells. The release of acetylhydrolase was concentration- and time-dependent and paralleled the release of PF 4, a marker for alpha-granules. The acetylhydrolase affinity for paf (Km) measured in sonicates of resting and thrombin-activated platelets was 8.3 +/- 1.5 microM vs. 10.6 +/- 1.5 microM, n = 5, n.s. in a "Mann Whitney" test. The latter Km was slightly but significantly different (P < 0.05, n = 5) from that of the thrombin-released acetylhydrolase (7.9 +/- 1.5 microM) and that of the latter was itself different from plasma acetylhydrolase (5.3 +/- 0.5, P < 0.05, n = 5). Addition of plasma (acid-treated to inactivate acetylhydrolase) decreased the Km value of supernatant acetylhydrolase to 6.1 +/- 1.4 microM. All preparations of acetylhydrolase exhibited similar pH requirements and sensitivity to various inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464350     DOI: 10.1007/bf02536639

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils.

Authors:  J Benveniste
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

2.  Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.

Authors:  Y Suzuki; M Miwa; M Harada; M Matsumoto
Journal:  Eur J Biochem       Date:  1988-02-15

3.  Hydrolysis of endogenous phospholipids by rat platelet phospholipase A2: ether or acyl bond and polar head group selectivity.

Authors:  O Colard; M Breton; G Bereziat
Journal:  Biochim Biophys Acta       Date:  1987-09-25

4.  Quantitation of paf-acether by release of endogenous platelet serotonin assessed by liquid chromatography with electrochemical detection.

Authors:  M J Bossant; E Ninio; D Delautier; G Bessou; J H Trouvin; J Benveniste
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

5.  Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor.

Authors:  G Ostermann; K Rühling; R Zabel-Langhennig; L Winkler; B Schlag; U Till
Journal:  Thromb Res       Date:  1987-08-01       Impact factor: 3.944

6.  A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

Authors:  M L Blank; T Lee; V Fitzgerald; F Snyder
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

7.  Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.

Authors:  M L Blank; M N Hall; E A Cress; F Snyder
Journal:  Biochem Biophys Res Commun       Date:  1983-06-15       Impact factor: 3.575

8.  Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia.

Authors:  M C Prévost; C Cariven; H Chap
Journal:  Biochim Biophys Acta       Date:  1988-10-14

9.  Comparison of three paf-acether receptor antagonist ginkgolides.

Authors:  R Korth; D Nunez; J Bidault; J Benveniste
Journal:  Eur J Pharmacol       Date:  1988-07-26       Impact factor: 4.432

10.  Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets.

Authors:  K Horigome; M Hayakawa; K Inoue; S Nojima
Journal:  J Biochem       Date:  1987-01       Impact factor: 3.387

View more
  5 in total

Review 1.  Metabolic processing of PAF.

Authors:  F Snyder
Journal:  Clin Rev Allergy       Date:  1994

Review 2.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

3.  Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes.

Authors:  H Yoshida; K Satoh; H Ishida; T Imaizumi; M Koyama; M Hiramoto; H Nakazawa; S Takamatsu
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

Review 4.  Role of biomarkers in developing new therapies for vascular disease.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 5.  Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.